Proof reading
would be nicde.
The first phase of clinical trials testing an AI-designed drug to treat a chronic lung disease is now underway, according to biotech startup Insilico Medicine. Using deep learning to discover new drugs is a relatively fresh development in the pharmaceutical industry, and machine learning algorithms are well-suited to the task …
Yeah, we missed out a word. It's fixed. Email corrections@theregister.com if you spot a typo, please.
FWIW we prioritize being accurate and technical. If you spot a typo in a story – like a missing word or wrong tense, or something – it's because whoever was writing or editing the piece had their mind on something more important, or was on a deadline.
C.